Ipo11 | importin 11
Physiological systems
20 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Homeostasis/metabolism Vision/eye Mortality/aging
17 No significant impact
4 Not tested
Data collections
Gene metrics:6Significant phenotypes
0Associated diseases
Expression examined in:49Adult tissues
25Embryo tissues
| preweaning lethality, complete penetrance | 1 supporting dataset | Ipo11tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
| abnormal lens morphology | 1 supporting dataset | Ipo11tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.21x10-5 | ||
| increased fasting circulating glucose level | 1 supporting dataset | Ipo11tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.87x10-6 | ||
| decreased circulating glucose level | 1 supporting dataset | Ipo11tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.41x10-5 | ||
| decreased circulating iron level | 1 supporting dataset | Ipo11tm1.1(KOMP)Vlcg | heterozygote | Early adult | 9.66x10-5 | ||
| embryonic lethality prior to tooth bud stage | 1 supporting dataset | Ipo11tm1.1(KOMP)Vlcg | homozygote | E12.5 | N/A * |
| | | | | | | | | | |
External links
No external links available for Ipo11.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.